Home > Financial Ratios > LYKA LABS

LYKA LABS
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

LYKA LABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 17.46-15.17-80.40385.973,765.48

What is the latest Core EBITDA Growth ratio of LYKA LABS ?

The latest Core EBITDA Growth ratio of LYKA LABS is 17.46 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202517.46
Mar2024-15.17
Mar2023-80.40
Mar2022385.97
Mar20213,765.48

How is Core EBITDA Growth of LYKA LABS Trending?

Years Core EBITDA Growth % Change
Mar2025 17.46
Positive
Mar2024 -15.17
Negative
Mar2023 -80.4
Negative
Mar2022 385.97
-89.75
Mar2021 3765.48 -

Other Financial Ratios of LYKA LABS


Compare Core EBITDA Growth ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹229.9 Cr -7.2% -18.7% -46.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,185.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹171,766.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,923.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹110,081.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹109,680.0 Cr 1.3% 1.3% -9.4% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

-7.2%

-18.7%

-46.6%

SENSEX

-0.3%

-0.1%

8.3%


You may also like the below Video Courses